Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant germ cell tumor other than dysgerminoma that arises from the ovary.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for malignant non-dysgerminomatous germ cell tumor of ovary.
3 publications have been identified in PubMed for malignant non-dysgerminomatous germ cell tumor of ovary. Research spans Review / Meta-Analysis (67%) and Epidemiology / Natural History (33%).
Bae J (2026). [PMID: 41775250](https://pubmed.ncbi.nlm.nih.gov/41775250/). *J Gynecol Oncol*. [Epidemiology / Natural History]
De Maria F (2025). [PMID: 40275685](https://pubmed.ncbi.nlm.nih.gov/40275685/). *J Gynecol Oncol*. [Review / Meta-Analysis]
Renz M (2025). [PMID: 40908761](https://pubmed.ncbi.nlm.nih.gov/40908761/). *Int J Gynaecol Obstet*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:34 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning malignant non-dysgerminomatous germ cell tumor of ovary
Updated May 5, 2026
A recent study investigates the impact of lymphadenectomy on survival outcomes in patients with stage I malignant ovarian germ cell tumors. The findings contribute to understanding treatment options for this rare cancer type.
A recent study evaluates the outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors following chemotherapy and surgery. The findings contribute to understanding treatment efficacy and patient prognosis in this rare cancer population.
A recent analysis of the CORSETT database highlights fertility-sparing surgery and treatment strategies for women with malignant ovarian germ cell tumors. This study provides insights into survival outcomes, contributing to the understanding of management options for this rare cancer.